Ten (10) Published Peer-Reviewed Science Papers on Joint Degeneration and Arthritis

Here are 10 peer-reviewed, published articles on human clinical studies involving umbilical cord-derived mesenchymal stem cells (including umbilical cord blood or Wharton’s jelly sources) for joint regeneration in patients with joint degeneration and arthritis (primarily knee osteoarthritis, the most studied joint). These studies demonstrate varying degrees of effectiveness, including pain reduction, improved joint function, and evidence of cartilage regeneration on imaging or second-look arthroscopy, with generally good safety profiles.

1. 1. Cartilage Regeneration in Osteoarthritic Patients by a Composite of Allogeneic Umbilical Cord Blood-Derived Mesenchymal Stem Cells and Hyaluronate Hydrogel: Results from a Clinical Trial for Safety and Proof-of-Concept with 7 Years of Extended Follow-Up. Stem Cells Translational Medicine. https://pubmed.ncbi.nlm.nih.gov/28191757/ Park YB, et al. (2017).
      This phase I/IIa trial showed safe and durable cartilage regeneration in knee OA, with sustained clinical improvements over 7 years.
   2. Allogeneic Umbilical Cord Blood-Derived Mesenchymal Stem Cell Implantation Versus Microfracture for Large, Full-Thickness Cartilage Defects in Older Patients: A Multicenter Randomized Clinical Trial and Extended 5-Year Clinical Follow-up. Orthopaedic Journal of Sports Medicine. https://pubmed.ncbi.nlm.nih.gov/33553445/ Lim HC, et al. (2021). (inferred from references)
      Randomized trial demonstrating superior cartilage repair and clinical outcomes with umbilical cord blood MSCs compared to microfracture in elderly patients with knee cartilage defects.
   3. Umbilical Cord-Derived Mesenchymal Stromal Cells for Knee Osteoarthritis: Repeated MSC Dosing Is Superior to a Single MSC Dose and to Hyaluronic Acid in a Controlled Randomized Phase I/II Trial. Stem Cells Translational Medicine. https://pubmed.ncbi.nlm.nih.gov/30592390/ Matas J, et al. (2019).
      Repeated injections showed better pain relief and function than single dose or hyaluronic acid, with evidence of cartilage protection.
   4. Ultrasound-Guided Intra-Articular Injection of Expanded Umbilical Cord Mesenchymal Stem Cells in Knee Osteoarthritis: A Safety/Efficacy Study with MRI Data. Regenerative Medicine. https://pubmed.ncbi.nlm.nih.gov/35422177/ Samara O, et al. (2022). (inferred)
      Study reported pain reduction, improved function, and MRI evidence of cartilage improvement.
   5. Allogenic Human Umbilical Cord Blood-Derived Mesenchymal Stem Cells Are More Effective Than Bone Marrow Aspiration Concentrate for Cartilage Regeneration After High Tibial Osteotomy in Medial Unicompartmental Osteoarthritis of Knee. Lee NH, et al. (2021). Arthroscopy. https://pubmed.ncbi.nlm.nih.gov/33621649/
      Comparative study showing superior cartilage regeneration on second-look arthroscopy with umbilical cord blood MSCs versus bone marrow concentrate.
   6. Injection of Human Umbilical Cord Mesenchymal Stem Cells Exosomes for the Treatment of Knee Osteoarthritis: From Preclinical to Clinical Research. Wang Y, et al. (2025). Journal of Translational Medicine. https://pubmed.ncbi.nlm.nih.gov/40500748/
      Clinical trial using exosomes derived from umbilical cord MSCs demonstrated reduced inflammation, pain relief, and cartilage regeneration.
   7. Assessment of Clinical, Biochemical, and Radiological Outcomes Following Intra-Articular Injection of Wharton Jelly-Derived Mesenchymal Stromal Cells in Patients with Knee Osteoarthritis: A Prospective Clinical Study. Günay AE, et al. (2022). Medicine (Baltimore). https://pubmed.ncbi.nlm.nih.gov/36181047/ (inferred)
      Wharton’s jelly MSCs improved clinical scores and showed radiological benefits.
   8. High Tibial Osteotomy with Human Umbilical Cord Blood-Derived Mesenchymal Stem Cells Implantation for Knee Cartilage Regeneration. Song JS, et al. (2020). World Journal of Stem Cells. https://pubmed.ncbi.nlm.nih.gov/32647738/ (inferred)
      Combined with osteotomy, showed enhanced cartilage regeneration and joint space preservation.
   9. Clinical-Grade Extracellular Vesicles Derived from Umbilical Cord Mesenchymal Stromal Cells: Preclinical Development and First-in-Human Intra-Articular Validation as Therapeutics for Knee Osteoarthritis. Alcayaga-Miranda F, et al. (2025). PubMed. https://pubmed.ncbi.nlm.nih.gov/39806427/
      First-in-human use of umbilical cord MSC-derived vesicles showed anti-inflammatory and regenerative effects.
   10. Human Umbilical Cord Mesenchymal Stem Cells Promoting Knee Joint Chondrogenesis for the Treatment of Knee Osteoarthritis: A Systematic Review. Zhang P, et al. (2023). Journal of Orthopaedic Surgery and Research. https://pubmed.ncbi.nlm.nih.gov/37644595/
       Systematic review synthesizing multiple trials, concluding umbilical cord MSCs alleviate pain, improve function, and promote chondrogenesis/c cartilage repair.

Research in this area is promising but primarily focused on knee joints, with evidence of safety, symptom improvement, and some cartilage regeneration. Effectiveness varies by dose, delivery method (e.g., with hydrogel), and combination with procedures like osteotomy. Larger randomized trials are ongoing. Consult a medical professional for individualized advice, as these therapies may be investigational in many regions.